BGBalqis Istiqomah Gusbela

Balqis Istiqomah Gusbela

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Balqis Istiqomah Gusbela has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of the COVID-19 pandemic on dental care utilization in Indonesia: a critical analysis with policy implications

    by Balqis Istiqomah Gusbela, Dedik Sulistiawan, Mita Juliawati, Daniel C.A. Nugroho, Diyah Fatmasari, Jason C. Hsu

    Background: Despite a substantial proportion of Indonesia’s population suffering from oral health issues, only a small percentage of those affected access professional dental care services. The COVID-19 pandemic has further exacerbated challenges in accessing healthcare, with dental care services experiencing particularly pronounced disruptions. This study examined the determinants of access to primary dental care in Indonesia prior and during the pandemic period. Methods: This study was a cross-sectional analysis that employed secondary data from Indonesian National Health Insurance (INHI) claim datasets to examine how oral and dental health services were utilized. We analyzed claims data from the INHI for 2019 and 2020, encompassing around 2,200,960 members, which represents approximately 1% of the total INHI enrollment. Logistic regression was employed to investigate the determinants of primary dental care access over this period, with a focus on examining how demographic and socioeconomic variables associated with access patterns. Results: In 2019, an estimated 2.3% of INHI members accessed primary dental care services, with this rate declining to 1.6% in 2020 following the onset of the COVID-19 pandemic. Access was significantly higher for specific demographic groups; females, children, married people, premium payers, wage workers, and residents living in the Java-Bali region had greater likelihood to access dental care services, both prior and during pandemic. Stratification analysis revealed that children in the first class accessed dental services more frequently than those in lower classes, and notable regional disparities were observed, with reduced access among second- and third-class members and those residing outside the Java-Bali region. The decrease in dental care use among government-subsidized participants in 2020 suggested that the COVID-19 pandemic had intensified barriers to care for vulnerable populations. Conclusions: COVID-19 pandemic has exacerbated difficulties in accessing dental care in Indonesia, particularly among government-subsidized and lower-class members, as well as those residing outside the Java-Bali region. Efforts to enhance support for vulnerable populations, improve regional healthcare infrastructure, and provide subsidies or incentives for dental care could help ensure more equitable access to essential services across Indonesia.

  • Open Access

    Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis

    by Balqis Istiqomah Gusbela, Min Huei Hsu, Chun Feng Huang, Meng Huang Wu, Daniel C. A. Nugroho, Muhammad Solihuddin Muhtar, Christine Y. Lu, Ming Hung Teng, Jason C. Hsu

    Background: Romosozumab and denosumab are two highly effective, widely used osteoporosis treatments. There has been no study directly comparing the effectiveness of romosozumab and denosumab in a clinical setting using large-scale, real-world data. Objectives: To evaluate the association between romosozumab and cardiovascular outcomes compared to denosumab in patients with osteoporosis. Design: Retrospective propensity score-matched cohort study. Methods: Using the TriNetX global health research network, we identified 59,058 patients aged 60 years or older with osteoporosis who initiated romosozumab ( n = 5200) or denosumab ( n = 53,858) between January 2019 and December 2024. After 1:1 propensity score matching, 2 balanced cohorts of 5192 patients each were obtained. Cardiovascular outcomes, including three-point major adverse cardiac events (3P-MACE ), 4P-MACE, 5P-MACE, individual MACE components, and other cardiovascular diseases (CVDs), were assessed across three follow-up periods: short-term (1 year), mid-term (3 years), and long-term (5 years). Primary analyses were conducted among patients without a prior cardiovascular history, and sensitivity analyses were performed among those with a prior cardiovascular history. Results: Among patients without a prior cardiovascular history, romosozumab was associated with significantly lower risks of 3P-MACE at 3-year (hazard ratio (HR) 0.645, 95% confidence interval (CI) 0.438–0.950, p = 0.023) and 5-year follow-up (HR 0.755, 95% CI 0.512–0.873, p = 0.028), and lower mortality at 3-year (HR 0.554, 95% CI 0.316–0.972, p = 0.038) and 5-year follow-up (HR 0.533, 95% CI 0.312–0.913, p = 0.028). No significant differences were observed at 1-year follow-up. In contrast, among patients with a prior cardiovascular history, romosozumab was associated with significantly higher risks of 4P-MACE, 5P-MACE, stroke, mortality, and chronic ischemic heart disease across all three follow-up time horizons. Conclusion: Romosozumab was associated with lower risks of 3P-MACE and mortality compared to denosumab among patients without a prior cardiovascular history at mid-term and long-term follow-up. In contrast, romosozumab was associated with consistently higher cardiovascular risks in patients with preexisting CVD. These findings highlight the importance of careful cardiovascular risk assessment prior to initiating romosozumab, particularly in patients with preexisting CVD. The 3P-MACE finding in patients without prior cardiovascular history is the primary confirmatory result; all other outcomes should be considered exploratory and hypothesis-generating.


  • Open Access

    Patient safety culture and identify factors associated with positive attitudes in private dental hospitals using the Indonesian Safety Attitude Questionnaire (SAQ-Indo): a cross-sectional study

    by Mita Juliawati, Kusuma Arbianti, Marta Juslily, Wita Anggraini, Balqis I Gusbela, Tri Erri Astoeti

    Introduction: Patient Safety culture (PSC) in healthcare represents a significant challenge on a global scale. However, in Indonesia data on the PSC among dental healthcare workers remain limited and knowledge about PSC among dental healthcare personnel is still insufficient. Consequently, there is a necessity for education and additional knowledge on this matter. This study aims to analyze the patient safety culture among dental healthcare workers and identify factors associated with positive attitudes in private dental hospitals using the Indonesian Safety Attitude Questionnaire (SAQ-Indo) Methods: A descriptive observational cross-sectional study design was used. The study was conducted among dental healthcare workers in two private dental hospitals in Jakarta and Semarang, Central Java. PSC factors were identified using bivariate analysis with Chi-square and simple logistic regression which classified responses as positive or negative based on the median of total score. The PSC score was the total score from 30 SAQ-Indo questions. Results: This study identified low, medium, good and very good safety culture levels based on percentile classification. Positive attitudes toward patient safety were found among participants from both private dental hospitals. Several factors were found to be associated with positive attitudes toward patient safety, including type of dental healthcare workers, age, level of education and practical experience. Conclusion: This study revealed patient safety attitudes among dental healthcare workers. The positive PSC scores were around 45% for the hospital in Jakarta and 32% for the hospital in Central Java. There is a need for socialization and education on PSC for dental healthcare workers at both private dental hospitals. Several factors were also found to be associated with positive attitudes toward patient safety, including professional role, age, educational level, and clinical experience. These findings may help increase awareness of patient safety at the hospital level in the future